Brief: Schrödinger Receives $111.3 Million Distribution From Sale Of Nimbus’S Tyk2 Inhibitor To Takeda
14/02/2023 12:03
Feb 14 (Reuters) - Schrodinger Inc SDGR.O :
* SCHRÖDINGER RECEIVES $111.3 MILLION DISTRIBUTION FROM SALE
OF
NIMBUS’S TYK2 INHIBITOR TO TAKEDA
Source text for Eikon: ID:nBw5T6X8ca
Further company coverage: SDGR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Schrodinger
See all newsBrief: Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Schrodinger Inc reports results for the quarter ended June 30 - Earnings Summary
Schrodinger Q2 revenue beats estimates, swings to profit
Brief: Schrodinger Q2 Revenue USD 58.889 Million Vs. IBES Estimate USD 47.2 Million
Brief: Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)